NCI

Dear Research Advocate, Mentioned here last week and the focus of an alliance member webinar earlier this week, the President issued an executive order (EO) extending and imposing new restrictions on worker and student visas. Our statement expresses opposition . Let’s face it — this EO essentially forces our nation to shoot itself in the foot. Bernat Navarro-Serer of the Johns Hopkins Science Policy Group (and a Research!America 2019 student microgrant recipient ) makes the case for sustaining our nation’s long-standing student visa programs . From the article: “ ...a suspension on work visas sends a strong message to current and future students seeking an education in the United States:...
Dear Research Advocate, Our nation’s research enterprise – and thus our society – has long benefitted mightily from the contributions of foreign-born scientists and engineers. In fact, nearly a third of the STEM workforce is foreign-born . A series of immigration-related actions by the executive branch, some already taken and others considered imminent, imperil academic, industry, and independent research across the country with consequences for our economy, our health, and our well-being. We are hosting an alliance member meeting on the state of play and advocacy opportunities next Monday, June 22 at 2 p.m. ET. Alliance members can register here . On Capitol Hill : Recent reports are that...
Fight Colorectal Cancer’s mission is to raise our voice to empower and activate a community of patients, fighters and champions to push for better policies and to support research, education and awareness for all those touched by this disease. This March, for National Colorectal Cancer Awareness Month, Fight Colorectal Cancer will be raising awareness that leads to action. Our mission cannot be fulfilled if people are simply aware that colorectal cancer exists. We must spur them to action in order to make a meaningful impact. This action must be tied to personal health advocacy (for example, getting screened), AND to policy and research. When all goals are working in harmony with one...
Ahead of World Cancer Day on February 4, the American Association for Cancer Research (AACR) would like to thank the thousands of laboratory researchers, physician-scientists, healthcare professionals and patient advocates around the globe and recognize their commitment to increasing the number of cancer survivors who are alive today. In the U.S., thanks to decades of federally funded cancer research supported by the National Institutes of Health (NIH) and the National Cancer Institute (NCI), we have seen a steady rise in the number of Americans who survive a cancer diagnosis. Our continued commitment to preventing and curing cancer comes at a time when, despite all the incredible progress...
What, in y our view, are the major challenges facing our nation’s research enterprise? Biomedical research is the driving force behind decades of advances that have improved the health of people in every corner of America—including the lives of those affected by breast cancer. With a robust and sustained investment in biomedical research, the possibilities would be endless. The National Institutes of Health (NIH) and its National Cancer Institute (NCI) have played a role in every major cancer prevention, detection and treatment advance in breast cancer for decades. Within the NIH, the NCI is the principal agency for cancer research and training. The NCI has funded numerous major breast...
Men’€™s Health Month increases the awareness of preventable health problems and encourages early detection and treatment of disease among males. According to MensHealthMonth.org , this is a time for health care providers, policy makers, the media, and individuals to encourage men to seek regular medical advice and early treatment for disease and injury. The Centers for Disease Control and Prevention have tips to help men live healthier lives and prevent disease. A report from Men’€™s Health Network suggests that men make nearly half as many visits to their physician for preventative care, yet they have nearly twice the risk of ischemic heart disease and other major illnesses. The Agency for...
Scientists at Memorial Sloan-Kettering Cancer Center , a Research!America member, have successfully treated a handful of leukemia patients with cutting-edge immune cell therapy. This therapy, similar to previous trials at the University of Pennsylvania and the National Cancer Institute, modifies the patient’€™s immune cells so that they recognize and kill the cancer cells. This experimental therapy provides a new avenue of treatment for patients who have undergone all of the traditional treatments like chemotherapy without achieving remission of the cancer. Read more about this exciting breakthrough in this New York Times article . The study’€™s senior author, Michael Sadelain, MD, PhD,...

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor